Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
| ▸ | PARK7 | Q99497 | 3/20 | 0.52 |
| ▸ | ALDH2 | P05091 | 3/20 | 0.50 |
| ▸ | ALDH3A1 | P30838 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | APAF1 | O14727 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25269189 | 0.96 | CYP1B1 (0.62) | CYP1B1ALDH1A1MAPTRAB9AGAA | |
| SCHEMBL125857 | 0.96 | CYP1B1 (0.58) | CYP1B1ALDH1A1MAPTRAB9AGAA | |
| SCHEMBL10324901 | 0.85 | CYP1B1 (0.54) | CYP1B1ALDH1A1MAPTRAB9AGAA | |
| SCHEMBL127851 | 0.85 | CYP1B1 (0.57) | CYP1B1ALDH1A1MAPTKDM4ECASP3 | |
| SCHEMBL127892 | 0.82 | PARK7 (0.44) | CYP1B1ALDH1A1MAPTRAB9AGAA | |
| SCHEMBL13578716 | 0.82 | ALDH1A1 (0.56) | CYP1B1ALDH1A1MAPTRAB9AGAA | |
| SCHEMBL12744280 | 0.81 | CYP1B1 (0.64) | CYP1B1ALDH1A1MAPTRAB9AGAA | |
| SCHEMBL128107 | 0.81 | CYP1B1 (0.56) | CYP1B1ALDH1A1MAPTKDM4ECASP3 | |
| SCHEMBL12744279 | 0.80 | CYP1B1 (0.63) | CYP1B1ALDH1A1MAPTRAB9AGAA | |
| SCHEMBL127843 | 0.79 | PARK7 (0.44) | CYP1B1ALDH1A1MAPTRAB9AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-20150123090-A1 | METHOD FOR THE DEPOSITION OF AN ORGANIC MATERIAL | BASF SE (DE) | 2015-05-07 | — | — | US | disclosed |
| US-20150123090-A1 | METHOD FOR THE DEPOSITION OF AN ORGANIC MATERIAL | BASF SE (DE) | 2015-05-07 | — | — | US | disclosed |
| WO-2013164761-A1 | METHOD FOR THE DEPOSITION OF AN ORGANIC MATERIAL | BASF SE (DE) | 2013-11-07 | — | — | WO | disclosed |
| EP-2532663-A1 | Naphthalenecarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-8309728-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2012-11-13 | — | — | US | disclosed |
| US-8309728-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2012-11-13 | — | — | US | disclosed |
| US-20120059168-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120059168-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-8084603-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2011-12-27 | — | — | US | disclosed |
| US-8084603-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2011-12-27 | — | — | US | disclosed |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| WO-2007074137-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059168-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | TST, NANS, NCDN | CYP1B1 1494/4885ALDH1A1 2384/4885MAPT 2667/4885 |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | ADSL, ALAD, EED | CYP1B1 3240/4885ALDH1A1 1083/4885MAPT 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.